genXone S.A. (WSE:GX1)

Market Cap	16.72M -13.7%
Revenue (ttm)	2.03M +16.3%
Net Income	-3.40M
EPS	-1.03
Shares Out	3.30M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,004
Average Volume	1,993
Open	5.08
Previous Close	5.06
Day's Range	5.06 - 5.10
52-Week Range	3.81 - 6.80
Beta	-0.39
RSI	64.20
Earnings Date	Feb 10, 2026

About genXone

genXone S.A. operates as a biotechnology company that offers nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally. The company operates in the field of molecular genetics and bioinformatics. It also develops solutions in the form of laboratory protocols, as well as bioinformatics tools, scripts, and algorithms enabling the use of nanopore sequencing in various areas of science and business, including genetic diagnostics, food industry, veterinary medicine, and agriculture. genXone S.A. was incor...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 2018
• Employees: 16
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: GX1

Financial Performance

In 2024, genXone's revenue was 1.79 million, a decrease of -25.33% compared to the previous year's 2.39 million. Losses were -3.93 million, 5.58% more than in 2023.